Boston Scientific announced that a cybersecurity incident first identified on August 25, 2026, is expected to have a material impact on its financial results. Due to operational disruptions in manufacturing and distribution, the company stated it is unlikely to meet its previously issued net sales growth and adjusted EPS guidance for the third quarter and full fiscal year 2026.
Key Details
- Financial Impact: The company has withdrawn its Q3 and full-year 2026 financial guidance provided on July 29, 2026, citing a likely material impact on results of operations.
- Operational Status: While manufacturing has resumed at most facilities and major distribution centers are now operating at or above normal levels, the company is still working to fully restore all affected systems and reduce order backlogs.
- Next Update: Boston Scientific intends to provide an updated operational and financial outlook during its scheduled Q3 2026 earnings call on October 28, 2026.